Sangamo Therapeutics, Inc. Common Stock (SGMO) is a publicly traded Healthcare sector company. As of May 20, 2026, SGMO trades at $0.18 with a market cap of $55.93M and a P/E ratio of -0.40. SGMO moved +31.04% today. Year to date, SGMO is -59.51%; over the trailing twelve months it is -75.61%. Its 52-week range spans $0.12 to $3.18. Analyst consensus is buy with an average price target of $6.00. Rallies surfaces SGMO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
SGMO financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. SGMO recently traded at $0.18. Market cap is $55.93M. P/E ratio is -0.40. Revenue is $39.55M.
| Metric | Value |
|---|---|
| Price | $0.18 |
| Market Cap | $55.93M |
| P/E Ratio | -0.40 |
| EPS | $-0.44 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.18 |
| 52-Week Low | $0.12 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $39.55M |
| Net Income | $-122.93M |
| Gross Margin | 0.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $39.55M | $-122.93M | $-0.44 |
| 2024 | $57.80M | $-97.94M | $-0.49 |
| 2023 | $176.23M | $-257.83M | $-1.48 |
| 2022 | $111.30M | $-192.28M | $-1.25 |
2 analysts cover SGMO: 0 strong buy, 1 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $6.00.